Kaiser Family Foundation By: Rachel Garfield and Priya Chidambaram The debate over school openings has highlighted the implications of the coronavirus pandemic for children and their families. While experts continue to gather data on children’s risk for contracting and transmitting coronavirus, current research suggests that though children are more likely to be asymptomatic and less […]
Bloomberg Quint The Covid-19 pandemic is harming the long-term health of low-income children, the Centers for Medicare & Medicaid Services said Wednesday. Vaccination rates, primary preventive care, and screenings among children in Medicaid and the Children’s Health Insurance Program have plummeted during the pandemic, the CMS said. Between March and May, vaccinations for children under […]
AZ Central By: Stephanie Innes The number of Arizonans without health insurance grew by nearly 64,000 people in 2019, well before the COVID-19 pandemic that may swell those ranks, new Census data says… In her blog post, Joan Alker of Georgetown University wrote that Latino children saw the largest jump in their already high uninsured […]
Biz Journal Verma unveiled the proposed rule in November, saying at the time there had been a proliferation of supplemental payment arrangements “where shady recycling schemes drive up taxpayer costs and pervert the system.” The rule drew widespread criticism from disparate interests. Joan Alker, executive director of the Center for Children and Families at Georgetown […]
The Hill By: Jessie Hellmann The Trump administration will not move forward with a proposed Medicaid rule that states, hospitals, insurers, patient advocates and members of both political parties warned could lead to massive cuts to the federal health care program for the poor… If finalized, the rule “would have forced states to face larger […]
Kaiser Health News By: Angela Hart and Samantha Young California is poised to become the first state to develop its own line of generic drugs, targeting soaring drug prices and stepping into a fiercely competitive drug market dominated by deep-pocketed pharmaceutical companies… “Other legislative efforts in Congress and in other states have focused on government […]
